Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
10.18
+0.20 (2.00%)
Mar 9, 2026, 1:38 PM EDT - Market open
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$1,499,972
Profits / Employee
$587,853
Market Cap
1.66B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Harmony Biosciences Holdings | 293 |
| Nuvation Bio | 291 |
| Innoviva | 159 |
| AnaptysBio | 104 |
| Nanobiotix | 103 |
NVAX News
- 5 days ago - Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 9 days ago - What's Going On With Novavax Stock On Friday? - Benzinga
- 10 days ago - Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof - Seeking Alpha
- 10 days ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 10 days ago - Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb - Benzinga
- 11 days ago - Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals - Reuters
- 11 days ago - Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - PRNewsWire